Paper40949487
Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances.
Mei J and 6 others. MedComm (2020), 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances. Papers, record 40949487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40949487
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References186
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31337756 | Mitochondrially-targeted APOBEC1 is a potent mtDNA mutator affecting mitochondrial function and organismal fitness in Drosophila. | Nat Commun | 2019 | https://conductscience.org/library/papers/31337756 | PubMed |
| 2 | 27502083 | A novel mutation m.8561C>G in MT-ATP6/8 causing a mitochondrial syndrome with ataxia, peripheral neuropathy, diabetes mellitus, and hypergonadotropic hypogonadism. | J Neurol | 2016 | https://conductscience.org/library/papers/27502083 | PubMed |
| 3 | 27626666 | A Phenotype-Driven Approach to Generate Mouse Models with Pathogenic mtDNA Mutations Causing Mitochondrial Disease. | Cell Rep | 2016 | https://conductscience.org/library/papers/27626666 | PubMed |
| 4 | 19933107 | Breaking the code of DNA binding specificity of TAL-type III effectors. | Science | 2009 | https://conductscience.org/library/papers/19933107 | PubMed |
| 5 | 26170609 | Leber hereditary optic neuropathy: current perspectives. | Clin Ophthalmol | 2015 | https://conductscience.org/library/papers/26170609 | PubMed |
| 6 | 2102678 | A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. | Nature | 1990 | https://conductscience.org/library/papers/2102678 | PubMed |
| 7 | 32202065 | Mitochondrial DNA in inflammation and immunity. | EMBO Rep | 2020 | https://conductscience.org/library/papers/32202065 | PubMed |
| 8 | 20007601 | Heterodimeric DNA methyltransferases as a platform for creating designer zinc finger methyltransferases for targeted DNA methylation in cells. | Nucleic Acids Res | 2010 | https://conductscience.org/library/papers/20007601 | PubMed |
| 9 | 15806097 | Highly efficient endogenous human gene correction using designed zinc-finger nucleases. | Nature | 2005 | https://conductscience.org/library/papers/15806097 | PubMed |
| 10 | 16298089 | Designer zinc-finger proteins and their applications. | Gene | 2006 | https://conductscience.org/library/papers/16298089 | PubMed |
| 11 | 34050192 | Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo. | Nat Commun | 2021 | https://conductscience.org/library/papers/34050192 | PubMed |
| 12 | 25206509 | Oxidative stress, mitochondrial damage and neurodegenerative diseases. | Neural Regen Res | 2013 | https://conductscience.org/library/papers/25206509 | PubMed |
| 13 | 35102133 | Human cleaving embryos enable efficient mitochondrial base-editing with DdCBE. | Cell Discov | 2022 | https://conductscience.org/library/papers/35102133 | PubMed |
| 14 | 28991104 | International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy. | J Neuroophthalmol | 2017 | https://conductscience.org/library/papers/28991104 | PubMed |
| 15 | 35745859 | Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35745859 | PubMed |
| 16 | 26735016 | High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. | Nature | 2016 | https://conductscience.org/library/papers/26735016 | PubMed |
| 17 | 32641830 | A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. | Nature | 2020 | https://conductscience.org/library/papers/32641830 | PubMed |
| 18 | 35551512 | Mitochondrial base editor induces substantial nuclear off-target mutations. | Nature | 2022 | https://conductscience.org/library/papers/35551512 | PubMed |
| 19 | 27096365 | Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. | Nature | 2016 | https://conductscience.org/library/papers/27096365 | PubMed |
| 20 | 39248161 | Mitophagy in acute central nervous system injuries: regulatory mechanisms and therapeutic potentials. | Neural Regen Res | 2025 | https://conductscience.org/library/papers/39248161 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958081 | Recombinant human growth hormone exposure preceding multisystem manifestations in a patient with MT-TL1 m.3243 A > G-related mitochondrial disease: a ten-year case report. | BMC Neurol | 2026 | https://conductscience.org/library/papers/42958081 | PubMed |
| 42553297 | Targeting mitochondria for the treatment of neurodegenerative diseases. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42553297 | PubMed |
| 42527628 | Metabolites with a message: impacts on epigenetics and implications for epimetabopathies. | EMBO Rep | 2026 | https://conductscience.org/library/papers/42527628 | PubMed |
| 42324372 | MTA-NPs induce preferential cytotoxicity, oxidative DNA damage, and mitochondrial apoptosis in human Hep-G2 hepatocellular carcinoma cells. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42324372 | PubMed |
| 42306084 | Mitochondrial genome microhomology-mediated editing by donor DNA delivery into mitochondria in human cells. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42306084 | PubMed |
| 41882155 | TSPO-PET highlights an atypical mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) phenotype. | Neurol Sci | 2026 | https://conductscience.org/library/papers/41882155 | PubMed |
| 41751913 | Somatic Mutations in Nuclear and Mitochondrial Genes of Mitochondrial Proteins in Primary and Recurrent Glioblastoma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41751913 | PubMed |
| 41312018 | CyDENT: A tale of CRISPR-free strand-specific base editor for nuclear and organellar genomes. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/41312018 | PubMed |
| 40949487 | Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40949487 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40949487
GET https://conductscience.org/api/papers/v1/40949487/references?page=2